SHZ:002773

Chengdu Kanghong Pharmaceutical Group Co., Ltd · SHZ · Healthcare · CNY · FY for 2025

Figures on this page computed 2026-11-08 13:30 UTC

Last close

n/aCNY

Market data

18.3xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed
- Computed from the filing for 2025
38.2%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
25.4%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
27.1%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.0004Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed

What it pays out is the furthest below its sector's middle: 0.40 against 0.54 on the market's range.

All from 100

lens 2 of 9

Sales

181

2016-12-31 to 2025-12-31100 at the start181

Sales: 100.00 on 2016-12-31 to 180.51 on 2025-12-31, up 81%.

Profit

234

2016-12-31 to 2025-12-31100 at the start234

Profit: 100.00 on 2016-12-31 to 234.11 on 2025-12-31, up 134%.

Shares in issue

106

2016-12-31 to 2025-12-31100 at the start106

Shares in issue: 100.00 on 2016-12-31 to 105.77 on 2025-12-31, up 6%.

Sales is at 180, Profit is at 234, Shares in issue is at 106, against 100 in 2016.

Sales is at 180, Profit is at 234, Shares in issue is at 106, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100181
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Profit, where the first year is 100234
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Shares in issue, where the first year is 100106
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY